{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:55:32Z","timestamp":1761155732762},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,8,10]],"date-time":"2013-08-10T00:00:00Z","timestamp":1376092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10557-013-6483-8","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T05:16:32Z","timestamp":1376025392000},"page":"569-572","source":"Crossref","is-referenced-by-count":13,"title":["Exercise-induced Myalgia may Limit the Cardiovascular Benefits of Statins"],"prefix":"10.1007","volume":"27","author":[{"given":"Lionel H.","family":"Opie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,10]]},"reference":[{"key":"6483_CR1","doi-asserted-by":"crossref","unstructured":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group. Lancet. 2002;360:7\u201322","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"6483_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","volume":"119","author":"PY Liu","year":"2009","unstructured":"Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009;119:131\u20138.","journal-title":"Circulation"},{"key":"6483_CR3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1365-2125.2012.04258.x","volume":"74","author":"WT Fang","year":"2012","unstructured":"Fang WT, Li HJ, Zhang H, Jiang S. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2012;74:744\u201356.","journal-title":"Br J Clin Pharmacol"},{"key":"6483_CR4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jch.12081","volume":"15","author":"A Briasoulis","year":"2013","unstructured":"Briasoulis A, Agarwal V, Valachis A, Messerli FH. Antihypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens (Greenwich). 2013;15:310\u201320.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"6483_CR5","doi-asserted-by":"crossref","unstructured":"Lavie O, Pinchev M, Rennert HS, Segev Y, Rennert G. The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol. 2013 May 26.","DOI":"10.1016\/j.ygyno.2013.05.025"},{"key":"6483_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6483_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","volume":"381","author":"PF Kokkinos","year":"2013","unstructured":"Kokkinos PF, Faselis C, Myers J, Panagiotakos D, Doumas M. Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study. Lancet. 2013;381:394\u20139.","journal-title":"Lancet"},{"key":"6483_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.163.5.553","volume":"163","author":"CM Ballantyne","year":"2003","unstructured":"Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553\u201364.","journal-title":"Arch Intern Med"},{"key":"6483_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)62027-3","volume":"380","author":"B Mihaylova","year":"2012","unstructured":"Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581\u201390.","journal-title":"Lancet"},{"key":"6483_CR10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage J. The safety of statins in clinical practice. Lancet. 2007;370:1781\u201390.","journal-title":"Lancet"},{"key":"6483_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7\u201322.","journal-title":"Lancet"},{"key":"6483_CR12","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","volume":"33","author":"J Bouitbir","year":"2012","unstructured":"Bouitbir J, Charles AL, Echaniz-Laguna A, et al. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC-1. Eur Heart J. 2012;33:1397\u2013407.","journal-title":"Eur Heart J"},{"key":"6483_CR13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ehj.2004.08.019","volume":"25","author":"MF Essop","year":"2004","unstructured":"Essop MF, Opie LH. Metabolic therapy for heart failure. Eur Heart J. 2004;25:1765\u20138.","journal-title":"Eur Heart J"},{"key":"6483_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","volume":"61","author":"S Larsen","year":"2013","unstructured":"Larsen S, Stride N, Hey-Mogensen M, et al. Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance. J Am Coll Cardiol. 2013;61:44\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"6483_CR15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjcard.2012.04.026","volume":"110","author":"DA Bookstaver","year":"2012","unstructured":"Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol. 2012;110:526\u20139.","journal-title":"Am J Cardiol"},{"key":"6483_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.20846","volume":"34","author":"S Fumagalli","year":"2011","unstructured":"Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, et al. Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study. Clin Cardiol. 2011;34:211\u20137.","journal-title":"Clin Cardiol"},{"key":"6483_CR17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","volume":"127","author":"BA Parker","year":"2013","unstructured":"Parker BA, Capizzi JA, Grimaldi AS, et al. Effect of statins on skeletal muscle function. Circulation. 2013;127:96\u2013103.","journal-title":"Circulation"},{"key":"6483_CR18","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/CIR.0b013e31826fb946","volume":"126","author":"M Guazzi","year":"2012","unstructured":"Guazzi M, Adams V, Conraads V, Halle M, Guazzi M, Adams V, et al. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261\u201374.","journal-title":"Circulation"},{"key":"6483_CR19","doi-asserted-by":"crossref","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jun 5. [Epub ahead of print].","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"6483_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2007.12.029","volume":"200","author":"AK Kearns","year":"2008","unstructured":"Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O\u2019Fallon KS, et al. The creatine kinase response to eccentric exercise with atorvastatin 10\u00a0mg or 80\u00a0mg. Atherosclerosis. 2008;200:121\u20135.","journal-title":"Atherosclerosis"},{"key":"6483_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","volume":"57","author":"H Sinzinger","year":"2004","unstructured":"Sinzinger H, O\u2019Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol. 2004;57:525\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"6483_CR22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjsm.2007.039974","volume":"42","author":"M Hamer","year":"2008","unstructured":"Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports Med. 2008;42:238\u201343.","journal-title":"Br J Sports Med"},{"key":"6483_CR23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/aje\/kws301","volume":"177","author":"P Schnohr","year":"2013","unstructured":"Schnohr P, Marott JL, Lange P, Jensen GB. Longevity in male and female joggers: the Copenhagen City Heart Study. Am J Epidemiol. 2013;177:683\u20139.","journal-title":"Am J Epidemiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-013-6483-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6483-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T11:15:50Z","timestamp":1646306150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-013-6483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,10]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["6483"],"URL":"https:\/\/doi.org\/10.1007\/s10557-013-6483-8","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,10]]}}}